Navigation Links
ASP Announces Availability of EVOTECH(TM) Endoscope Cleaner and Reprocessor - First Commercially Available System to Eliminate Manual Cleaning of Endoscopes
Date:12/16/2008

EVOTECH(TM) System Offers Healthcare Workers Consistent Cleaning

and Complete Confidence

IRVINE, Calif., Dec. 16 /PRNewswire/ -- Advanced Sterilization Products (ASP) is pleased to announce the availability of the EVOTECH(TM) Endoscope Cleaner and Reprocessor, the first commercially available system to eliminate labor-intensive manual cleaning of endoscopes. The results of the EVOTECH(TM) System establish a consistently high standard of automated endoscope cleaning and high-level disinfection that is comparable to professional society guidelines for manual cleaning.

By removing the need to manually clean, the EVOTECH(TM) System eliminates the risk of human variation in endoscope cleaning. In addition, the EVOTECH(TM) System's 33-minute or less reprocessing cycle time provides fast turn-around of instrumentation and enables healthcare workers to spend more time completing patient-related activities.

"With the EVOTECH(TM) System's exceptional automation and technology, you can be confident that endoscopes are reprocessed safely and consistently," said Karen Borg, Worldwide Vice President of Marketing at ASP. "The EVOTECH(TM) System is a trailblazer and one more example of how ASP is continually delivering innovative infection prevention solutions that meet our customers' needs."

The EVOTECH(TM) System features:

  • Integrated Minimum Effective Concentration (MEC) monitoring that eliminates the need to handle high-level disinfectant, limiting the chance of staff exposure.
  • Automated leak detection at the beginning and end of the cycle, which helps ensure endoscope integrity.
  • Built-in alcohol flush that complies with SGNA recommendations to promote drying of endoscopes.
  • Single-use high-level disinfection using glutaraldehyde-free CIDEX(R) OPA Concentrate Solution.
  • Dual, independent basins that offer cleaning and reprocessing in 33 minutes or less.
  • Convenient hands-free operation.
  • Audible alarm can be turned on to alert of cycle completion.

The EVOTECH(TM) System is indicated for use with high-level disinfectant CIDEX(R) OPA Concentrate Solution and an enzymatic detergent (CIDEZYME(R) GI) to achieve cleaning and high-level disinfection of heat sensitive (>60 degrees Celsius) semi-critical endoscopes. Manual cleaning of medical devices (endoscopes) is not required prior to placement in the EVOTECH(TM) System when selecting those cycles that contain a wash stage. Manual cleaning of medical devices (endoscopes) is required when selecting the Disinfect only or Disinfect/Alcohol Flush Cycle.

For more information about the EVOTECH(TM) System, please visit www.evotechecr.com or call 1-888-783-7723.

About ASP

Advanced Sterilization Products (ASP), division of Ethicon, Inc., a Johnson & Johnson company, has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health and safety for those who matter most. Our pioneering technology, global distribution, and established leadership position enable us to simplify the process of buying and operating infection prevention products and services every day, for thousands of medical facilities around the world. This in turn enables our customers to focus on what they do best - preventing infection and saving lives.

www.evotechecr.com


'/>"/>
SOURCE Advanced Sterilization Products
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)
2. Cardiums InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
3. Jazz Pharmaceuticals Announces Reduction in Force to Reflect Streamlined Operations
4. Bioamber announces worlds first bio-based succinic acid plant: helping to reduce dependence on fossil fuels
5. OmegaGenesis Announces Angiogenesis Application Collaboration
6. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
7. Banyan Biomarkers Announces Issuance of U.S. Patent for Biomarkers for Traumatic Injury
8. Osteotech Announces Stock Repurchase Program
9. Martek Announces Fourth Quarter and FY 2008 Financial Results
10. Helix BioPharma Announces Q1 2009 Financial Results
11. Neogen Announces New Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Milwaukee, WI (PRWEB) , ... March 22, 2017 , ... ... federal scientific research agencies as outlined in the Administration’s recently published fiscal year 2018 ... for the National Institutes of Health (NIH) by $5.8 billion or roughly 20% of ...
(Date:3/22/2017)... March 22, 2017   Invitae Corporation ... information companies, today announced the availability of a ... Spinal Muscular Atrophy (SMA) , a neuromuscular disease ... disorders among infants as well as a significant ... new test, announced during the American College of ...
(Date:3/20/2017)... Linda, CA (PRWEB) , ... March 20, 2017 ... ... and require expensive and laborious sample preparation methods in order to reduce the ... often underappreciated outside of the area of elemental analysis. , This presentation ...
(Date:3/20/2017)... PUYALLUP, Wash. , March 20, 2017 ... leading provider of ethical review of clinical research, announced ... Review Solution TM (SRS) for NIH-funded multi-site ... among its 2,300 institution clients, WIRB has an extensive ... upon our trusted status as the IRB of record ...
Breaking Biology Technology:
(Date:3/2/2017)... -- Summary This report provides all the ... its partnering interests and activities since 2010. Download ... Partnering Deals and Alliance since 2010 report provides an ... the world,s leading life sciences companies. On ... inclusion of the most up to date deal and ...
(Date:3/2/2017)... March 2, 2017 Australian stem cell and ... CYP), has signed an agreement with the Monash Lung ... Biomedicine Discovery Institute and Department of Pharmacology at Monash ... further preclinical study to support the use of Cymerus™ ... Asthma is a chronic, long term ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
Breaking Biology News(10 mins):